Skip to main content
Veterinary Medicines

Halofusol 0.5 mg/ml oral solution for calves

Authorised
  • Halofuginone lactate

Product identification

Medicine name:
Halofusol 0.5 mg/ml oral solution for calves
Halofusol 0,5 mg/ml orale oplossing voor kalveren
Active substance:
  • Halofuginone lactate
Target species:
  • Cattle (newborn calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Halofuginone lactate
    0.61
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle (newborn calf)
      • Meat and offal
        13
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BX01
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • bottle of 1000 ml
  • bottle of 500 ml
  • bottle of 250 ml
  • box containing 1 bottle of 1000 ml with a 4 ml metering pump
  • box containing 1 bottle of 1000 ml
  • box containing 1 bottle of 500 ml with a 4 ml metering pump
  • box containing 1 bottle of 500 ml
  • box containing 1 bottle of 250 ml with a 4 ml metering pump
  • box containing 1 bottle of 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 124622
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0351/001
Concerned member states:
  • Belgium
  • Cyprus
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 2/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."